- $47.24m
- $49.57m
- $48.10m
- 51
- 37
- 92
- 63
Annual balance sheet for Apyx Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 41.9 | 30.9 | 10.2 | 43.7 | 31.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17.3 | 21.3 | 18.3 | 14.2 | 15.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 66.1 | 60.7 | 43 | 70.4 | 56.4 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7.21 | 6.87 | 7.59 | 7.15 | 6.74 |
Other Long Term Assets | |||||
Total Assets | 74.1 | 68.7 | 51.8 | 79.2 | 64.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9.15 | 13.2 | 11.8 | 12.7 | 10.7 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 10.4 | 15 | 14.2 | 52.5 | 50.6 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 63.7 | 53.7 | 37.6 | 26.7 | 14.2 |
Total Liabilities & Shareholders' Equity | 74.1 | 68.7 | 51.8 | 79.2 | 64.8 |
Total Common Shares Outstanding |